Maynard Um
-
-
-
-
-
-
-
InMed Reports Third Quarter Fiscal 2026 Financial Results and Provides Business Update
-
-
-
-
-
-
-
InMed Provides Update on BayMedica Operations and Strengthens Focus on Pharmaceutical Development Pipeline
-
-
-
-
-
-
-
InMed Pharmaceuticals adds John Bathery to board of directors
-
-
-
-
-
-
-
InMed Pharmaceuticals Inc. (INM) Files for 3.9M Share Offering by Selling Stockholders
-
-
-
-
-
-
-
InMed Appoints CBIZ as New Auditor in Connection with CBIZ's Acquisition of Marcum's Attest Business, Provides Update on Special Meeting and Makes Modifications to Existing SEPA
-
-
-
-
-
-
-
InMed Announces INM-089 Intravitreal Formulation in the Treatment of Dry Age-Related Macular Degeneration
-
-
-
-
-
-
-
InMed Pharmaceuticals (INM) Enters $10M Standby Equity Purchase Agreement
-
410,557 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

